Maravai LifeSciences Holdings Inc - Class A
Research Maravai LifeSciences Holdings Inc - Class A (MRVI) on Bullrun: market cap USD 1.33B. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerMRVI
- ExchangeNASDAQ
- CountryUnited States
- SectorHealthcare
- IndustryBiotechnology
- CurrencyUSD
- Market capUSD 1.33B
- Financial periodQ2 2026
- RevenueUSD 51.44M
- Net income-USD 12.42M
- Free cash flowUSD 3.62M
- Gross margin40.1%
Valuation Snapshot
latest market cap is USD 1.33B.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | USD 185.74M | -USD 130.80M | -USD 70.72M | 18.3% | -0.9 | USD 216.89M | USD 291.77M | USD 212.38M |
| FY2024 | USD 259.19M | -USD 144.80M | -USD 22.19M | 41.8% | -1.05 | USD 322.40M | USD 295.93M | USD 325.29M |
| FY2023 | USD 288.95M | -USD 138.40M | USD 60.67M | 48.5% | -0.9 | USD 574.96M | USD 524.15M | USD 416.75M |
| FY2022 | USD 883.00M | USD 490.70M | USD 518.89M | 80.9% | 1.67 | USD 632.14M | USD 527.44M | USD 545.22M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-25 | USD 1.33B | n/a | n/a | n/a |
| 2025 | 2025-12-31 | USD 472.30M | n/a | n/a | n/a |
| 2024 | 2024-12-31 | USD 773.77M | n/a | n/a | n/a |
| 2023 | 2023-12-29 | USD 865.84M | 36.4 | n/a | n/a |
| 2022 | 2022-12-30 | USD 1.88B | 8.0 | n/a | n/a |
| 2021 | 2021-12-31 | USD 5.51B | 27.2 | n/a | n/a |
About Maravai LifeSciences Holdings Inc - Class A
Maravai LifeSciences Holdings, Inc., a life sciences company, provides products that enable the development of drug therapies, vaccines, drug therapies, cell and gene therapies, and diagnostics North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin and Central America. It operates through two segments: TRILINK and CYGNUS.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Maravai LifeSciences Holdings Inc - Class A's market cap?
Maravai LifeSciences Holdings Inc - Class A's market capitalization is USD 1.33B.
What does Maravai LifeSciences Holdings Inc - Class A do?
Maravai LifeSciences Holdings, Inc., a life sciences company, provides products that enable the development of drug therapies, vaccines, drug therapies, cell and gene therapies, and diagnostics North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin and Central America. It operates through two segments: TRILINK and CYGNUS.